Quest Diagnostics Share Holder Equity 2010-2024 | DGX

Quest Diagnostics share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
  • Quest Diagnostics share holder equity for the quarter ending March 31, 2024 was $6.469B, a 6.26% increase year-over-year.
  • Quest Diagnostics share holder equity for 2023 was $6.342B, a 6.95% increase from 2022.
  • Quest Diagnostics share holder equity for 2022 was $5.93B, a 8.53% decline from 2021.
  • Quest Diagnostics share holder equity for 2021 was $6.483B, a 4.79% decline from 2020.
Quest Diagnostics Annual Share Holder Equity
(Millions of US $)
2023 $6,342
2022 $5,930
2021 $6,483
2020 $6,809
2019 $5,687
2018 $5,267
2017 $4,955
2016 $4,660
2015 $4,713
2014 $4,330
2013 $3,973
2012 $4,186
2011 $3,715
2010 $4,054
2009 $4,011
Quest Diagnostics Quarterly Share Holder Equity
(Millions of US $)
2024-03-31 $6,469
2023-12-31 $6,342
2023-09-30 $6,463
2023-06-30 $6,287
2023-03-31 $6,088
2022-12-31 $5,930
2022-09-30 $6,272
2022-06-30 $6,450
2022-03-31 $6,415
2021-12-31 $6,483
2021-09-30 $6,432
2021-06-30 $5,940
2021-03-31 $6,790
2020-12-31 $6,809
2020-09-30 $6,446
2020-06-30 $5,881
2020-03-31 $5,703
2019-12-31 $5,687
2019-09-30 $5,654
2019-06-30 $5,509
2019-03-31 $5,341
2018-12-31 $5,267
2018-09-30 $5,365
2018-06-30 $5,263
2018-03-31 $5,066
2017-12-31 $4,955
2017-09-30 $4,828
2017-06-30 $4,733
2017-03-31 $4,663
2016-12-31 $4,660
2016-09-30 $4,694
2016-06-30 $4,569
2016-03-31 $4,666
2015-12-31 $4,713
2015-09-30 $4,621
2015-06-30 $4,344
2015-03-31 $4,271
2014-12-31 $4,330
2014-09-30 $4,210
2014-06-30 $4,119
2014-03-31 $4,020
2013-12-31 $3,973
2013-09-30 $3,872
2013-06-30 $3,939
2013-03-31 $4,227
2012-12-31 $4,186
2012-09-30 $4,198
2012-06-30 $4,021
2012-03-31 $3,896
2011-12-31 $3,715
2011-09-30 $3,545
2011-06-30 $3,451
2011-03-31 $3,238
2010-12-31 $4,054
2010-09-30 $3,881
2010-06-30 $3,947
2010-03-31 $3,929
2009-12-31 $4,011
2009-09-30 $3,938
2009-06-30 $3,766
2009-03-31 $3,532
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $15.437B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.911B 0.00
DaVita (DVA) United States $12.399B 15.40
Elanco Animal Health (ELAN) United States $8.920B 23.14
Encompass Health (EHC) United States $8.544B 21.87
Chemed (CHE) United States $8.213B 25.46
Option Care Health (OPCH) United States $4.898B 18.54
RadNet (RDNT) United States $4.340B 90.37
Amedisys (AMED) United States $2.999B 21.24
Astrana Health (ASTH) United States $2.312B 31.26
LifeStance Health (LFST) United States $2.022B 0.00
Addus HomeCare (ADUS) United States $1.939B 27.74
U.S Physical Therapy (USPH) United States $1.388B 37.15
Pennant (PNTG) United States $0.677B 35.75
Aveanna Healthcare Holdings (AVAH) United States $0.492B 0.00
Atai Life Sciences (ATAI) Germany $0.224B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Novo Integrated Sciences (NVOS) United States $0.016B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00